Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

Market Cap	5.40B +18.8%
Revenue (ttm)	7.32B -8.4%
Net Income	-85.17K
EPS	-0.00
Shares Out	1.48B
PE Ratio	n/a
Forward PE	n/a
Dividend	0.01 (0.22%)
Ex-Dividend Date	n/a

Volume	391,207,356
Average Volume	101,410,776
Open	3.490
Previous Close	3.590
Day's Range	3.490 - 3.950
52-Week Range	2.720 - 4.690
Beta	0.37
RSI	63.31
Earnings Date	Apr 23, 2026

About SHE:002589

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materials, herbal medicine, and patent medicine. It is also involved in the wholesale of biochemical, psychotropic, narcotic, and toxic drugs for medical use...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 2,897
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002589

Financial Performance

In 2024, SHE:002589's revenue was 7.97 billion, a decrease of -0.85% compared to the previous year's 8.03 billion. Earnings were 20.62 million, an increase of 1.50%.